Dyadic International Inc (DYAI)

[ronpopeil]

after market today ABBV announced partnership with group DYAI referenced in 1st Quarter report:
Today 6/5/2020 Investors Business Daily
AbbVie (ABBV) is jumping into the race for a coronavirus treatment, the drugmaker said Friday as ABBV stock climbed higher.01:39
The pharmaceutical company said it will partner with a company called Harbour BioMed, Utrecht University and Erasmus Medical Center to study an antibody that could treat or prevent Covid-19, the respiratory illness caused by the new form of coronavirus.
Harbour, Utrecht and Erasmus first discovered the antibody, called neutralizing antibody 47D11. It targets a portion of the spike protein known to coat the outside of SARS-CoV-2, the new form of the coronavirus. By blocking the spike protein, researchers hope to treat or prevent Covid-19.

This paragraph is from DYAI 1st Quarter report:
Dyadic, in collaboration with Erasmus Medical Center, Utrecht University, and the University of Veterinary Medicine Hannover ("TiHo"), with whom Dyadic previously worked with on the EU ZAPI project, have developed a potential COVID-19 vaccine candidate which, based on preliminary results, has demonstrated successful engineering of C1 to express high levels of a potential SARS-CoV-2 vaccine candidate. This consortium has submitted proposals for program funding to pharmaceutical organizations and government agencies.